Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13th.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, August 22, 2023
Information
Tags: 
Biotechnology, General Health, Health, Pharmaceutical, Medical Supplies, Morgan Stanley, Webcast, Morgan, Johnson & Johnson, JNJ, Conference, NYSE, Eastern Time Zone
Geotags: 
NEW JERSEY, UNITED STATES, NORTH AMERICA, NEW YORK
Organisation: 
JOHNSON & JOHNSON
Stock Symbol: 
NYSE:JNJ
Summary
Key Points: 
  • Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13th.
  • Joaquin Duato, Chairman of the Board and Chief Executive Officer and John Reed, Executive Vice President Pharmaceuticals R&D will represent the Company in a session scheduled at 10:10 a.m. (Eastern Time).
  • A webcast and podcast replay will be available approximately 48 hours after the live webcast.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20230822087768/en/


Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13th. Joaquin Duato, Chairman of the Board and Chief Executive Officer and John Reed, Executive Vice President Pharmaceuticals R&D will represent the Company in a session scheduled at 10:10 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

Copyright: 
Copyright Business Wire 2023